|
|
Integrin Targeted Therapy for the Treatment of Ovarian Cancer
|
3R41CA168228-01A1S1
|
$158,842
|
$158,842
|
Calzone, Frank
|
APPLIED INTEGRIN SCIENCES, INC.
|
|
|
Understanding the origin,initiation,and progression of high-grade serous ovarian
|
1K99CA179137-01
|
$97,200
|
$97,200
|
Kim, Jaeyeon
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Understanding the origin and pathogenesis of epithelial ovarian cancer
|
5F32CA159523-03
|
$57,734
|
$57,734
|
Kim, Jaeyeon
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
$1,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
$865
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-07
|
$3,092,811
|
$61,856
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Role of the BMP SMADs in Oncogenesis
|
5R01CA138628-04
|
$333,108
|
$333,108
|
Pangas, Stephanie
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-29
|
$612,504
|
$30,625
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Analysis of BRCA1 recombination functions
|
5R01CA095175-10
|
$277,509
|
$138,755
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-22
|
$1,669,985
|
$333,997
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens
|
5R01CA158119-02
|
$514,415
|
$514,415
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Multifunctional nanoparticles for targeting aberrant tumorigenic pathways
|
5R01CA135242-04
|
$337,720
|
$111,448
|
Sengupta, Shiladitya
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-14
|
$4,589,191
|
$1,101,406
|
Stampfer, Meir
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Psychological stress, associate biologic mediators, and ovarian cancer risk
|
5R01CA163451-02
|
$389,016
|
$389,016
|
Tworoger, Shelley
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
|
5U24CA160034-03
|
$3,019,843
|
$754,961
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
|
|
Nanosystems Biology Cancer Center 2
|
5U54CA151819-04
|
$2,287,859
|
$366,057
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
|
Carle Cancer Center Community Clinical Oncology Program
|
2U10CA035195-30
|
$828,213
|
$41,411
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
|
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
|
3U01CA062502-19S1
|
$841,154
|
$8,412
|
DOWLATI, AFSHIN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-23
|
$4,740,480
|
$47,405
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-23S2
|
$37,026
|
$370
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Next-generation mouse gene-targeting technology to model tumorigenesis
|
1R21CA181859-01
|
$241,316
|
$79,634
|
Wang, Zhenghe
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC
|
5R44CA139841-03
|
$619,304
|
$154,826
|
PRABHAKARPANDIAN, BALABHASKAR
|
CFD RESEARCH CORPORATION
|
|
|
Cytogenetic and Molecular Studies of Chromosome 22
|
5R01CA039926-25
|
$344,242
|
$86,061
|
EMANUEL, BEVERLY
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Delaware/Christiana Care Community Clinical Oncology Program
|
5U10CA045418-27
|
$1,543,934
|
$46,318
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
5K05CA136967-05
|
$139,821
|
$6,991
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Breast and Other Cancers in the California Teachers Cohort
|
5R01CA077398-15
|
$2,365,386
|
$236,539
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
2P30CA033572-30
|
$2,042,489
|
$20,425
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-30S1
|
$125,000
|
$1,250
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-30S2
|
$52,354
|
$524
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-30S3
|
$10,680
|
$107
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-18
|
$1,136,278
|
$79,539
|
Sturtz, Keren
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
|
Integrative Cancer Genomics: Drivers, Pathways and Drugs
|
5R01CA164729-02
|
$358,131
|
$53,720
|
Pe'er, Dana
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
|
The BARD1 tumor suppressor and breast cancer
|
1R01CA172272-01A1
|
$332,000
|
$166,000
|
BAER, RICHARD
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S3
|
$3,546,194
|
$35,462
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S4
|
$75,000
|
$750
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S5
|
$125,000
|
$1,250
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S6
|
$49,718
|
$497
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Mutual regulation of PTEN and P-REX2a in normal and cancer cells
|
5R01CA155117-03
|
$80,232
|
$20,058
|
Parsons, Ramon
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA006516-48S1
|
$114,538
|
$2,291
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant
|
3P30CA006516-48S3
|
$12,500
|
$250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant
|
3P30CA006516-48S4
|
$50,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant
|
5P30CA006516-48
|
$10,435,722
|
$208,714
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Investigate role of microRNA cluster 183-96-182 in DNA repair and radiosensitivit
|
5R01CA142698-04
|
$331,098
|
$165,549
|
Chowdhury, Dipanjan
|
DANA-FARBER CANCER INST
|
|
|
Elafin as a biomarker in serous ovarian cancers and basal-like breast tumors
|
1R21CA156021-01A1
|
$224,499
|
$112,250
|
DRAPKIN, RONNY
|
DANA-FARBER CANCER INST
|
|
|
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
|
1U01CA176058-01
|
$725,869
|
$254,054
|
HAHN, WILLIAM
|
DANA-FARBER CANCER INST
|
|
|
BRCA1 Function in Post-Damage Nuclear Foci
|
5R01CA136512-05
|
$480,837
|
$120,209
|
LIVINGSTON, DAVID
|
DANA-FARBER CANCER INST
|
|
|
Novel Tools for Familial Risk Prediction
|
1R21CA177233-01
|
$225,021
|
$45,004
|
PARMIGIANI, Giovanni
|
DANA-FARBER CANCER INST
|
|
|
Chemotherapy Near Death: Modifiable Factors and Outcomes in Ovarian Cancer
|
1K07CA166210-01A1
|
$177,120
|
$177,120
|
Wright, Alexi
|
DANA-FARBER CANCER INST
|
|
|
Dartmouth Center for Cancer Nanotechnology Excellence
|
5U54CA151662-04
|
$2,138,631
|
$705,748
|
Baker, Ian
|
DARTMOUTH COLLEGE
|
|
|
CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA045807-28
|
$1,542,411
|
$92,545
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
Total relevant funding to Ovarian Cancer for this search: $100,558,561
|
